REQUEST A DEMO
Total
USD $0.00
Search more companies

Welgene Biotech Co., Ltd. (威健股份有限公司) (Taiwan, China)

Main Activities: Ambulatory Health Care Services
Full name: Welgene Biotech Co., Ltd. Profile Updated: December 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Welgene Biotech Co., Ltd. is professional in genetic analysis and medical testing, sales of genetic medical products: testing reagents, commodities and clinical medical instruments. The company was founded in 2003 and located in Taipei City.

Headquarters
12F., No.3, Park St., Nangang Dist
Taipei City; Taipei City;

Contact Details: Purchase the Welgene Biotech Co., Ltd. (威健股份有限公司) report to view the information.

Website: http://www.welgene.com.tw

Basic Information
Total Employees:
Purchase the Welgene Biotech Co., Ltd. (威健股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Welgene Biotech Co., Ltd. (威健股份有限公司) report to view the information.
Financial Auditors:
Purchase the Welgene Biotech Co., Ltd. (威健股份有限公司) report to view the information.
Incorporation Date:
January 30, 2003
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
30.31%
Purchase this report to view the information.
2.1%
Purchase this report to view the information.
1.4%
Purchase this report to view the information.
1.25%
Purchase this report to view the information.
Subsidiaries
威茂股份有限公司
100%
微傳股份有限公司
83%
Company Performance
Financial values in the chart are available after Welgene Biotech Co., Ltd. (威健股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
18.39%
Total operating revenue
18.46%
Operating profit (EBIT)
35.66%
EBITDA
0.1%
Net Profit (Loss) for the Period
69.5%
Total Assets
8.13%
Total Equity
-1.67%
Operating Profit Margin (ROS)
0.19%
Net Profit Margin
0.19%
Return on Equity (ROE)
0.26%
Debt/Equity
10.45%
Quick Ratio
0.08%
Cash Ratio
-0.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?